Autres langues Alvotech

Actions

ALVO

LU2458332611

Recherche biotechnologique et médicale

Cours en clôture Nasdaq 05/10/2026			Varia. 5j.	Varia. 1 janv.
6,110 ^USD	+12,11%		+3,21%	+19,10%

05:54	Alvotech et Lotte Biologics signent un nouveau partenariat de fabrication de substances médicamenteuses	MT
06/10	Alvotech et Lotte Biologics signent un accord de fabrication aux États-Unis pour des médicaments biosimilaires	MT

Autres langues

05:54	Alvotech, Lotte Biologics Sign New Drug Substance Manufacturing Partnership
06/10	Alvotech, Lotte Biologics Sign US Manufacturing Agreement for Biosimilar Medicines
06/10	Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
05/10	Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi
05/10	Alvotech Gets US FDA Approval For Additional Manufacturing Capacity For Simlandi Biosimilar; Shares Up Pre-Bell
05/10	Alvotech Gets US FDA Nod for Additional Manufacturing Capacity for Humira Biosimilar
05/10	Alvotech : FDA approves additional U.S. manufacturing capacity for SIMLANDI, Alvotech’s biosimilar to Humira
05/10	Alvotech : FDA approves additional U.S. manufacturing capacity for SIMLANDI, Alvotech's biosimilar to Humira
05/10	FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®
05/10	Alvotech Receives FDA Approval for Additional U.S. Manufacturing Capacity for SIMLANDI
29/09	Alvotech : Half yearly fcial & audit reports / ltd reviews - ALVOTECH
29/09	Alvotech : Half yearly fcial & audit reports / ltd reviews - Alvotech Q2 2026 - Unaudited Condensed Consolidated Interim Financial Statements first 6 months - EN
21/09	Alvotech(NasdaqGM:ALVO) added to S&P Global BMI Index
16/09	Alvotech Shares Rise After Double Upgrade From Barclays
16/09	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed's Rate Announcement
14/09	Certain Stock Options of Alvotech are subject to a Lock-Up Agreement Ending on 14-SEP-2026.
14/09	Certain Restricted Stock Units of Alvotech are subject to a Lock-Up Agreement Ending on 14-SEP-2026.
14/09	Certain Warrants of Alvotech are subject to a Lock-Up Agreement Ending on 14-SEP-2026.
14/09	Certain Ordinary Shares of Alvotech are subject to a Lock-Up Agreement Ending on 14-SEP-2026.
10/09	Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says
07/09	Takeda Files BPCIA Suit Against Alvotech For Vedolizumab Biosimilar
02/09	Alvotech and Lotus Enter Agreement for Durvalumab and Emicizumab Biosimilars
31/08	Alvotech Shares Rise After FDA Accepts Biologics License Application for AVT80
31/08	Alvotech's Application for Proposed Entyvio Biosimilar Accepted for US FDA Review
31/08	Alvotech Says FDA Accepted Biologics License Application for AVT80